Validation Study of the Korean Version of the EORTC QLQ-HDC29

Seoul National University

Status: Completed

Conditions: Quality of Life After Stem Cell Transplantation

Study type: Observational

Funder types: Other

Identifiers

NCT01208532

HDC29_Kor

Details and patient eligibility

About

The aim of this study is to evaluate the reliability and validity of the Korean version of the European Organization for Research and Treatment of Cancer High-dose Chemotherapy module (EORTC HDC-29).

Enrollment: 226 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who are aged more than 18 years
• Patients who are diagnosed with hematologic malignancies and who are planned to receive high-dose chemotherapy followed by allogeneic or autologous stem cell transplantation (SCT)
• Patients who agree with the informed consent

Exclusion criteria

• Patients who are unable to complete the questionnaire due to the serious physical or psychological morbidity